Bulletin
Investor Alert

Freeline Therapeutics Holdings PLC ADR

NAS: FRLN

GO
/marketstate/country/us

Market closed

/zigman2/quotes/219907679/composite

$

16.97

Change

-0.23 -1.34%

Volume

Volume 21,528

Sep 22, 2020, 4:00 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/219907679/composite

Previous close

$ 17.20

$ 16.97

Change

-0.23 -1.34%

Day low

Day high

$16.82

$17.26

Open
Open: 17.26

52 week low

52 week high

$15.25

$21.69

Open

Market cap

$597.61M

Average volume

215,642

P/E ratio

N/A

Rev. per Employee

N/A

EPS

N/A

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/frln

MarketWatch News on FRLN

  1. Freeline Therapeutics started at overweight with $27 stock price target at J.P. Morgan

    7:39 a.m. Sept. 1, 2020

    - Tomi Kilgore

  2. Freeline Therapeutics started at outperform with $28 stock price target at Wedbush

    7:32 a.m. Sept. 1, 2020

    - Tomi Kilgore

  3. Freeline Therapeutics started at outperform with $32 stock price target at Evercore ISI

    7:12 a.m. Sept. 1, 2020

    - Tomi Kilgore

  4. Freeline Therapeutics to offer 7.35 mln ADS in IPO, priced at $16 to $18 each

    6:31 a.m. Aug. 3, 2020

    - Ciara Linnane

  5. UK biotech Freeline Therapeutics sets IPO terms

    6:31 a.m. Aug. 3, 2020

    - Ciara Linnane

/news/nonmarketwatch/company/us/frln

Other News on FRLN

/news/pressrelease/company/us/frln

Press Releases on FRLN

Rates »

Link to MarketWatch's Slice.